CD4 and inflammatory bowel disease: The B. fragilis PSA can suppress inflammatory bowel disease and experimental autoimmune encephalomyelitis (EAE) through activating helper T cells that express the surface protein CD4 (CD4+ T cells) through a mechanism dependent on the major histocompatibility complex class II (MHCII) [63].